poisar

Stocks · News reference

8-K filing — Processa Pharmaceuticals, Inc. (PCSA)

SEC EDGARJul 29, 2026, 11:35 AMSEC EDGAR

Filed: 2026-07-29 AccNo: 0001493152-26-035099 Size: 9 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Jul 29, 2026, 11:35 AM
Checked
Jul 29, 2026, 11:35 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 4, 2026, 9:25 PMSEC EDGAR

    8-K filing — Processa Pharmaceuticals, Inc. (PCSA)

    Filed: 2026-08-04 AccNo: 0001493152-26-036032 Size: 226 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

    Read original at edgar